Diabetic peripheral neuropathy (DPN) is a common complication of both type 1 and 2
diabetes. It is a leading cause of lower-limb amputation and disabling neuropathic pain …

Diabetic neuropathy, with its major clinical sequels, notably neuropathic pain, foot ulcers,
and autonomic dysfunction, is associated with substantial morbidity, increased risk of …

Abstract The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of
Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic …

Diabetic peripheral neuropathy and metabolic syndrome (MetS) are both global health
challenges with well‐established diagnostic criteria and significant impacts on quality of life …

OBJECTIVE To study incident diabetic polyneuropathy (DPN) prospectively during the first
13 years after a screening-based diagnosis of type 2 diabetes and determine the associated …

The global epidemic of prediabetes and diabetes has led to a corresponding epidemic of
complications of these disorders. The most prevalent complication is neuropathy, of which …

Objective To determine the associations between individual metabolic syndrome (MetS)
components and peripheral neuropathy in a large population‐based cohort from Pinggu …

Frustratingly, disease-modifying treatments for diabetic neuropathy remain elusive.
Glycaemic control has a robust effect on preventing neuropathy in individuals with type 1 but …

Diabetic neuropathies are the most frequent complications of diabetes, contributing to high
morbidity, excess mortality, reduced quality of life, and increased healthcare costs …

Objective To determine the prevalence of neuropathy stratified by glycemic status and the
association between extensive anthropometric measurements and neuropathy. Patients and …